With increasing evidence surfacing from the Human Microbiome Project, the coevolution of the hostmicrobiome superorganism and the unperturbed microbial component of the dyad has appeared to render sustainable host health. This coevolution has been proved by a consistently growing body of science to have a significant role in shaping evolving phenotypes in humans. The microbiota ecosystems develop, restricted to their epithelial niches by the host immune system, concomitantly with the host chronological development, providing early modulation of physiological host development and functions for nutrition, immunity, and resistance to pathogens at all ages. As a result of these findings, the human microbiome has often been dubbed as the “second genome”, attracting massive investment and research potential. Followed by globally relevant activities that have delved deeper into understanding the role of the microbiome on human health, the symbiosis between the human host and the microbiome, now deemed as the human holobiont, has emerged as the next frontier of embedding precision care into health regimens.

1. Product Definition 

2. Market Scope 

3. Research Methodology 

4. Market Overview 

5. Industry Insights 

6. Market Dynamics 

7. Competitive Landscape

8. Global Skin Microbiome Modulators Market (by Product Type) 

9. Global Skin Microbiome Modulators Market, (by Application) 

10. Global Skin Modulators Market (by Distribution Channels) 

11. Global Skin Microbiome Modulators Market (by Region) 

12. Company Profiles